One of those CHEK2 variants is p.(Ile157Thr), which has been described to confer increased cancer risk for solid tumors and chronic lymphocytic leukemia [23, 24]. The gene discussed is CHEK2; the disease is B-cell chronic lymphocytic leukemia.